J3 Bioscience Appoints Dr. Stephanie Singer as Medical Director

June 24, 2025 05:57 PM CEST | By EIN Presswire
 J3 Bioscience Appoints Dr. Stephanie Singer as Medical Director
Image source: EIN Presswire
SALT LAKE CITY, UT, UNITED STATES, June 24, 2025 /EINPresswire.com/ -- J3 Bioscience, Inc, a commercialization-stage women’s health company, today announced the appointment of Dr. Stephanie Singer as Medical Director. A board-certified gynecologist, expert laparoscopic surgeon, and founder of three private medical practices, Dr. Singer will serve as the company’s clinical voice and advisor on its growing portfolio of women’s health solutions, including LivRing®, the first and only FDA-cleared, over-the-counter intravaginal ring that provides continuous moisturizing and lubricating benefit for up to 7 days.

Dr. Singer brings more than 20 years of clinical and surgical experience with a focus on pelvic pain, sexual health, hormone therapy, and age management. She is the founder of Park City Gynecology, Park City Medesthetix, and Cenegenics Park City, and has cared for thousands of women managing the intimate effects of hormonal changes, vaginal dryness, and other health concerns that often go under-treated or unspoken.

“I’ve spent my career helping women feel confident, comfortable, and in control of their health,” said Dr. Stephanie Singer. “Joining the leadership team at J3 Bioscience feels like a natural extension of the work I’ve been doing for years, listening to women, understanding their needs, and finding solutions that truly improve their quality of life. I’m proud to support a company that is bringing thoughtful, evidence-based innovation to women’s health.”

As Medical Director, Dr. Singer will contribute to clinical communications, medical education efforts, and strategic stakeholder engagement. She will also serve as an advisor on product innovation and medical positioning as J3 advances its long-term value creation strategy.

“Dr. Singer brings not only deep clinical expertise but an ability to translate patient experience into meaningful medical guidance,” said John Fair, CEO of J3 Bioscience. “Her insight strengthens our ability to connect with both healthcare professionals and the women we serve, and her leadership will be instrumental as we advance accessible solutions to address unmet needs in women’s health.”

“Dr. Singer is a passionate advocate and highly respected clinician who brings deep expertise to our team,” said Tim S. Glassett, JD, MBA, Chairman of the Board of J3 Bioscience. “Her unique understanding of what women are experiencing and what’s missing in their care makes her an ideal partner as we expand access to safe and effective solutions like LivRing.”

Dr. Singer is board-certified by the American Board of Obstetrics and Gynecology, a Fellow of the American College of Obstetricians and Gynecologists (ACOG), and an associate member of the American Academy of Cosmetic Surgery. She served as President of the Summit and Wasatch County Medical Society in 2021.

About J3 Bioscience, Inc.:
J3 Bioscience, Inc. is a commercialization-stage, specialty women’s health and wellness company headquartered in Salt Lake City, Utah. Focused on conditions that impact women throughout the course of their lives, J3 Bioscience develops innovative solutions that address long-overlooked needs in women’s health. With a strong commitment to clinical integrity, user-centered design, and long-term impact, J3 Bioscience is advancing a new standard of care in women’s health.

About LivRing:
LivRing, is the first and only intravaginal ring that is FDA-cleared as a vaginal lubricant and vaginal moisturizer. LivRing is available without a prescription and represents a new and effective solution for women experiencing vaginal dryness. For more information, please visit www.Livring.com

Madelyn De Los Santos
Putnam Insights LLC
[email protected]
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles